InvestorsHub Logo
Followers 0
Posts 798
Boards Moderated 0
Alias Born 07/27/2018

Re: boston745 post# 23939

Saturday, 05/11/2019 3:14:16 PM

Saturday, May 11, 2019 3:14:16 PM

Post# of 41258
What Zimmer has is hip. They dont have spine. Spine was a way to increase their bottom line by penetrating that arena. An improvement in hip cannibalizes their existing business they have. Spine is market they don't dominate. So an improvement in spinal devices seems to help their bottom line more than an improvement in hip this way.

never interested in Valeo. Valeo was Sintx way to commcerialize a product until a hip implant could be succesfully developed.



SiNi is disruptive enough to be ground breaking in the spinal arena to be a superior device and take market share. increased fusion natural antibacterial antifungal. Over questionably safe titanium and rejected oxidizing peek. The only way it's not superior if there is some ace up the sleeve for the nay sayer that SiNi is completely biodegradable.

Either Zimmer dropped the ball in spine or SiNi is secretly trash. I`d say IF valeo became a financial threat at some time up to this point we'd be seeing the partnerships and #metoo products.

Sini doped peek, Hips, spine and SiNi coatings have existed long enough to see some publicly disclosed attempts at adoption from Zimmer. This is the timeline. All we see is Hanson dancing around about secret product pipelines. Obviously not something the investor is comfortable hanging it's hat on. Not something new out of the mouth of Hanson either.

I'll give you Jafry, but the rest suggests an incompetent Zimmer or a Zimmer waiting for Kyocera or Coorstek to ramp something. A dependent Zimmer.

Cerasurf can take market share from Ceramtec Biolox. What if Coorstek doesnt want to be friends with Zimmer? What if lack of Zimmer #metoo Valeo isn't something that Zimmer decided for them self? The only person I see out there that makes sense deciding this FOR Zimmer is Stryker. That would be in Stryker's best interest.

Coorstek seems about as strategically positioned six degrees from kevin bacon as Zimmer is or was. From both SINTX hub and CTL.

with C5 Medical Werks of Grand Junction, which the family had owned.

The combined company becomes a manufacturing, development and design firm specializing in orthopedic implants and instruments with four manufacturing plants, three product-development facilities and a headquarters in Fort Worth.

Through the two existing companies, the new firm already has been making medical devices for some of the bigger players in that industry in the U.S., including Johnson & Johnson, Stryker and Zimmer, said Jonathan Coors, CoorsTek Medical CEO.



So based on this Coorstek doesn't seem in cahoots with Stryker against Zimmer. Just Zimmer being incompetent or dependent on ceramic manufacturers taking their sweet time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News